{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T13:27:34Z","timestamp":1768742854511,"version":"3.49.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University of L\u2019Aquila, L\u2019Aquila, Italy"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.prp.2016.11.004","type":"journal-article","created":{"date-parts":[[2016,11,11]],"date-time":"2016-11-11T18:16:55Z","timestamp":1478888215000},"page":"58-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Expression of pro-fibrotic and anti-fibrotic molecules in dimethylnitrosamine-induced hepatic fibrosis"],"prefix":"10.1016","volume":"213","author":[{"given":"Roberta","family":"Sferra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Vetuschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Pompili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"Gaudio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Speca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Latella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2016.11.004_bib0005","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.jhep.2004.12.008","article-title":"Fibrosis in chronic liver disease: diagnosis and management","volume":"42","author":"Pinzani","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.prp.2016.11.004_bib0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prp.2016.11.004_bib0015","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1586\/egh.10.47","article-title":"Update on the pathophysiology of liver fibrosis","volume":"4","author":"Pinzani","year":"2010","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.prp.2016.11.004_bib0020","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: a translational success story","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.prp.2016.11.004_bib0025","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/cphy.c120035","article-title":"Hepatic stellate cells and liver fibrosis","volume":"3","author":"Puche","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.prp.2016.11.004_bib0030","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.prp.2016.11.004_bib0035","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.3748\/wjg.v20.i23.7260","article-title":"Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: an update","volume":"20","author":"Elpek","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prp.2016.11.004_bib0040","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis\u2014a common pathway to organ injury and failure","volume":"372","author":"Rockey","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2016.11.004_bib0045","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.prp.2016.11.004_bib0050","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2001-17550","article-title":"History, heterogeneity, developmental, biology, and functions of quiescent hepatic stellate cells","volume":"21","author":"Geerts","year":"2001","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.prp.2016.11.004_bib0055","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/gut.2005.088690","article-title":"Emerging insights into transforming growth factor \u03b2\/smad signal in hepatic fibrogenesis","volume":"56","author":"Inagaki","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.prp.2016.11.004_bib0060","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","article-title":"Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ","volume":"117","author":"Iredale","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prp.2016.11.004_bib0065","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/hep.21806","article-title":"Profibrogenic transforming growth factor beta\/activin receptor-like kinase5 signalling via connective tissue growth factor expression in hepatocytes","volume":"46","author":"Weng","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.prp.2016.11.004_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb03205.x","article-title":"Smad3: a key player in pathogenetic mechanisms dependent on TGF-\u03b2","volume":"995","author":"Roberts","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.prp.2016.11.004_bib0075","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ejcb.2008.01.012","article-title":"Integrins and the activation of latent transforming growth factor beta1\u2014an intimate relationship","volume":"87","author":"Wipff","year":"2008","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.prp.2016.11.004_bib0080","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.biocel.2007.11.026","article-title":"The role of proteases in transforming growth factor beta activation","volume":"40","author":"Jekins","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.prp.2016.11.004_bib0085","doi-asserted-by":"crossref","first-page":"167sr1","DOI":"10.1126\/scitranslmed.3004700","article-title":"Therapy for fibrotic diseases: nearing the starting line","volume":"5","author":"Friedman","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.prp.2016.11.004_bib0090","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20031675","article-title":"SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis","volume":"199","author":"Yoshida","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.prp.2016.11.004_bib0095","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3748\/wjg.v10.i7.1037","article-title":"Ginkgo biloba extract reverses CCl4-induced liver fibrosis in rats","volume":"10","author":"Luo","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prp.2016.11.004_bib0100","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1478-3231.2009.02011.x","article-title":"Targeted disruption of Smad 3 confers resistence to the development of dimethylnitrosamine-induced hepatic fibrosis in mice","volume":"29","author":"Latella","year":"2009","journal-title":"Liver Int."},{"key":"10.1016\/j.prp.2016.11.004_bib0105","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/33.8.2410480","article-title":"A simple micromethod for collagen and total protein determination in formalin-fixed paraffin embedded sections","volume":"33","author":"Lopez-De Leon","year":"1985","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.prp.2016.11.004_bib0110","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/37.3.2465335","article-title":"Estimation of collagen contento of liver speciments: variation among animals and among hepatic lobes in cirrhotic rats","volume":"37","author":"Gascon- Barr\u00e8","year":"1989","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.prp.2016.11.004_bib0115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.0959-9673.2004.00377.x","article-title":"Smad3 as a mediator of the fibrotic response","volume":"85","author":"Flanders","year":"2004","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.prp.2016.11.004_bib0120","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jss.2007.12.103","article-title":"Inhibition of TGF-beta signaling via Smad7 gene transfer decreases intimal hyperplasia after vascular injury","volume":"144","author":"Tsai","year":"2008","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.prp.2016.11.004_bib0125","doi-asserted-by":"crossref","first-page":"H1282","DOI":"10.1152\/ajpheart.00910.2006","article-title":"Regulation of collagen synthesis by inhibitory Smad7 in cardiac myofibroblasts","volume":"293","author":"Wang","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.prp.2016.11.004_bib0130","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1073\/pnas.90.2.770","article-title":"Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death","volume":"90","author":"Kulkarni","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.prp.2016.11.004_bib0135","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/31693","article-title":"Smad2 role in mesoderm formation, leftright patterning and craniofacial development","volume":"393","author":"Nomura","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.prp.2016.11.004_bib0140","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1073\/pnas.95.7.3667","article-title":"The tumor suppressor Smad4\/DPC4 is essential for epiblast proliferation and mesoderm induction in mice","volume":"95","author":"Yang","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.prp.2016.11.004_bib0145","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0092-8674(00)81730-4","article-title":"Smad3 mutant mice develop metastatic colorectal cancer","volume":"94","author":"Zhu","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.prp.2016.11.004_bib0150","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/emboj\/18.5.1280","article-title":"Targeted disruption of Smad3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta","volume":"18","author":"Yang","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.prp.2016.11.004_bib0155","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1128\/MCB.19.4.2495","article-title":"Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction","volume":"19","author":"Datto","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.prp.2016.11.004_bib0160","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1053\/j.gastro.2008.04.038","article-title":"Hepatocytes-specific Smad7 expression attenuates TGF beta mediated fibrogenesis and protects against liver damage","volume":"135","author":"Dooley","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prp.2016.11.004_bib0165","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/j.gastro.2013.01.056","article-title":"Transforing growth factor beta signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1","volume":"144","author":"Yang","year":"2013","journal-title":"Gastroentereology"},{"key":"10.1016\/j.prp.2016.11.004_bib0170","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1053\/j.gastro.2015.11.039","article-title":"Epithelial transforming growth factor-\u03b2 signaling does not contribute to liver fibrosis but protects mice from cholangiocarcinoma","volume":"150","author":"Mu","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prp.2016.11.004_bib0175","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.dld.2010.02.008","article-title":"Taurocholic Acid prevents biliary damage induced by hepatic artery ligation in cholestatic rats","volume":"42","author":"Glaser","year":"2010","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.prp.2016.11.004_bib0180","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/embor.2009.276","article-title":"Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing","volume":"11","author":"Margadant","year":"2010","journal-title":"EMBO Rep."},{"key":"10.1016\/j.prp.2016.11.004_bib0185","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/labinvest.2011.155","article-title":"The function of integrin-linked kinase in normal and activated stellate cells: implications for fibrogenesis in wound healing","volume":"92","author":"Shafiei","year":"2012","journal-title":"Lab. Invest."},{"key":"10.1016\/j.prp.2016.11.004_bib0190","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ceb.2011.08.005","article-title":"Mechanisms of integrin activation and trafficking","volume":"23","author":"Margadant","year":"2011","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.prp.2016.11.004_bib0195","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2008.04.009","article-title":"Inhibition of integrin av\u03b26 on cholangiocytes blocks transforming growth factor-\u03b2 activation and retards biliary fibrosis progression","volume":"135","author":"Patsenker","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prp.2016.11.004_bib0200","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jss.2008.05.023","article-title":"Integrin alphavbeta6 and mediators of extracellular matrix deposition are up-regulated in experimental biliary atresia","volume":"154","author":"Nadler","year":"2009","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.prp.2016.11.004_bib0205","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.2353\/ajpath.2010.100425","article-title":"The coagulation system contributes to alphaVbeta6 integrin expression and liver fibrosis induced by cholestasis","volume":"177","author":"Sullivan","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2016.11.004_bib0210","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1359-6101(97)00010-5","article-title":"Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts","volume":"8","author":"Grotendorst","year":"1997","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.prp.2016.11.004_bib0215","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0945-053X(02)00055-0","article-title":"Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy","volume":"21","author":"Blom","year":"2002","journal-title":"Matrix Biol."},{"issue":"February (2)","key":"10.1016\/j.prp.2016.11.004_bib0220","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/hep.27425","article-title":"Connective tissue growth factor and integrin \u03b1v\u03b26: a new pair of regulators critical for ductular reaction and biliary fibrosis in mice","volume":"61","author":"Pi","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.prp.2016.11.004_bib0225","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.2741\/4067","article-title":"Regulation of hepatic stellate cells by connective tissue growth factor","volume":"17","author":"Huang","year":"2012","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"10.1016\/j.prp.2016.11.004_bib0230","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1152\/ajprenal.00320.2009","article-title":"Noncanonical TGF-beta pathways, mTORC1 and Abl, in renal interstitial fibrogenesis","volume":"298","author":"Wang","year":"2010","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.prp.2016.11.004_bib0235","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drudis.2006.12.008","article-title":"Targeting mammalian target of rapamycin (mTOR) for health and diseases","volume":"12","author":"Tsang","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.prp.2016.11.004_bib0240","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1158\/0008-5472.CAN-08-2146","article-title":"Distinct roles for mammalian target of rapamycin complexes in the fibroblast response to transforming growth factor beta","volume":"69","author":"Rahimi","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2016.11.004_bib0245","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1681\/ASN.2008111186","article-title":"The role of the mammalian target of rapamycin (mTOR) in renal disease","volume":"20","author":"Lieberthal","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.prp.2016.11.004_bib0250","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bcp.2010.09.011","article-title":"Differential modulation f the cytokine-induced MMP-9\/TIMP-1 protease-antiprotease system by the mTOR inhibitor rapamycin","volume":"81","author":"Osman","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.prp.2016.11.004_bib0255","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000329327","article-title":"Angiotensin II activation of mTOR results in tubulointerstitial fibrosis through loss of N-cadherin","volume":"34","author":"Whaley-Connell","year":"2011","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.prp.2016.11.004_bib0260","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/art.27498","article-title":"Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis","volume":"62","author":"Yoshizaki","year":"2010","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.prp.2016.11.004_bib0265","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/BOR.0b013e32833de1a7","article-title":"Peroxisome proliferator-activated receptor \u03b3: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosis","volume":"22","author":"Wei","year":"2010","journal-title":"Curr. Opin. Rheumatol."},{"issue":"9","key":"10.1016\/j.prp.2016.11.004_bib0270","first-page":"1123","article-title":"A role for mammalian target of rapamycin (mTOR) pathway in non alcoholic steatohepatitis related-cirrhosis","volume":"25","author":"Kubrusly","year":"2010","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.prp.2016.11.004_bib0275","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cellsig.2011.11.008","article-title":"Peroxisome proliferator-activated receptor-\u03b3 cross-regulation of signaling events implicated in liver fibrogenesis","volume":"24","author":"Zhang","year":"2012","journal-title":"Cell. Signal."},{"key":"10.1016\/j.prp.2016.11.004_bib0280","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00018-012-1046-x","article-title":"Peroxisome proliferator-activated receptor-\u03b3 as a therapeutic target for hepatic fibrosis: from bench to bedside","volume":"70","author":"Zhang","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.prp.2016.11.004_bib0285","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00403-009-0959-1","article-title":"Activation of peroxisome proliferator-activated receptor-gamma inhibits transforming growth factor-beta1 induction of connective tissue growth factor and extracellular matrix in hypertrophic scar fibroblasts in vitro","volume":"301","author":"Zhang","year":"2009","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.prp.2016.11.004_bib0290","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1499-3872(12)60210-0","article-title":"Organ fibrosis inhibited by blocking transforming growth factor-\u03b2 signaling via peroxisome proliferator-activated receptor \u03b3 agonists","volume":"11","author":"Deng","year":"2012","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.prp.2016.11.004_bib0295","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1002\/art.24761","article-title":"Loss of peroxisome proliferator activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis","volume":"60","author":"Kapoor","year":"2009","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.prp.2016.11.004_bib0300","doi-asserted-by":"crossref","first-page":"e13778","DOI":"10.1371\/journal.pone.0013778","article-title":"PPAR\u03b3 downregulation by TGF\u00df in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis","volume":"5","author":"Wei","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2016.11.004_bib0305","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00011-010-0226-0","article-title":"Effectiveness of the PPAR\u03b3 agonist, GW570, in liver fibrosis","volume":"59","author":"Yang","year":"2010","journal-title":"Inflamm. Res."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033816306410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033816306410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T14:09:37Z","timestamp":1568556577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033816306410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0344033816306410"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2016.11.004","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of pro-fibrotic and anti-fibrotic molecules in dimethylnitrosamine-induced hepatic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2016.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}